Recruiting studies: Lichen Plano Pilaris

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Nemolizumab to Treat Lichen Planopilaris, a Noncontrolled, Prospective, Pilot Study.
Phase 4 · 1 location(s) · The Skin Center Dermatology Group · NCT07396168 The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Lichen Planopilaris in Routine Clinical
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT06512753 Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07487948 A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Phase 2/Phase 3 · 61 location(s) · Priovant Therapeutics, Inc. · NCT07532603

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.